Abbott Laboratories
ABT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,616,000 | $6,896,000 | $9,882,000 | $9,799,000 |
| Short-Term Investments | $351,000 | $383,000 | $288,000 | $450,000 |
| Receivables | $6,925,000 | $6,565,000 | $6,218,000 | $6,487,000 |
| Inventory | $6,194,000 | $6,570,000 | $6,173,000 | $5,157,000 |
| Other Curr. Assets | $2,570,000 | $2,256,000 | $2,663,000 | $2,346,000 |
| Total Curr. Assets | $23,656,000 | $22,670,000 | $25,224,000 | $24,239,000 |
| Property Plant & Equip (Net) | $11,733,000 | $11,276,000 | $10,278,000 | $10,112,000 |
| Goodwill | $23,108,000 | $23,679,000 | $22,799,000 | $23,231,000 |
| Intangibles | $6,647,000 | $8,815,000 | $10,454,000 | $12,739,000 |
| Long-Term Investments | $886,000 | $799,000 | $766,000 | $903,000 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15,384,000 | $5,975,000 | $4,917,000 | $3,972,000 |
| Total NC Assets | $57,758,000 | $50,544,000 | $49,214,000 | $50,957,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $81,414,000 | $73,214,000 | $74,438,000 | $75,196,000 |
| Liabilities | – | – | – | – |
| Payables | $4,195,000 | $4,295,000 | $4,607,000 | $4,408,000 |
| Short-Term Debt | $1,754,000 | $1,325,000 | $2,481,000 | $999,000 |
| Tax Payable | $594,000 | $492,000 | $343,000 | $306,000 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,614,000 | $7,729,000 | $8,058,000 | $7,392,000 |
| Total Curr. Liab. | $14,157,000 | $13,841,000 | $15,489,000 | $13,105,000 |
| LT Debt | $13,521,000 | $14,548,000 | $15,465,000 | $18,252,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1,372,000 | $1,218,000 | $1,841,000 | $2,072,000 |
| Other NC Liab. | $4,463,000 | $4,780,000 | $4,738,000 | $5,743,000 |
| Total NC Liab. | $19,356,000 | $20,546,000 | $22,044,000 | $26,067,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $896,000 | $949,000 | $943,000 | $956,000 |
| Total Liabilities | $33,513,000 | $34,387,000 | $37,533,000 | $39,172,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $25,153,000 | $24,869,000 | $24,709,000 | $24,470,000 |
| Retained Earnings | $47,261,000 | $37,554,000 | $35,257,000 | $31,528,000 |
| AOCI | -$7,906,000 | -$7,839,000 | -$8,051,000 | -$8,374,000 |
| Other Equity | -$16,844,000 | -$15,981,000 | -$15,229,000 | -$11,822,000 |
| Total Equity | $47,664,000 | $38,603,000 | $36,686,000 | $35,802,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $237,000 | $224,000 | $219,000 | $222,000 |
| Total Liab. & Tot. Equity | $81,414,000 | $73,214,000 | $74,438,000 | $75,196,000 |
| Net Debt | $7,659,000 | $8,977,000 | $8,064,000 | $9,452,000 |